Carlsmed, Inc.

Carlsmed, Inc.

CARL
Carlsmed, Inc.US flagNASDAQ
15.60
USD
+0.08
- -
424.08MMarket Cap
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.72
6.68
3.55
2.49
Basic EPS, GAAP
-0.99
-6.11
-2.12
-1.43
Free Cash Flow per Basic Share
-0.92
-6.31
-2.08
-1.36
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-1.74
-2.66
3.71
3.09
Tangible Book Value per Share
-1.74
-2.66
3.71
3.09
Basic Weighted Avg Shares
19
4
14
25
Sales/Revenue/Turnover
14
27
51
63
Operating Margin (%)
-134.93
-88.8
-60.53
-61.09
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
-19
-24
-30
-36
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
-137.16
-89.3
-58.67
-57.42
Working Capital
4
41
112
97
LT Debt
9
17
17
21
Total Equity
-46
-71
99
84
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
-49.36

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
1
1
LT Borrowings
15
15
15
LT Finance Leases
1
1
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27
27
27
Market Capitalization
329
246
283

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
127
115
110
Cash, Cash Equivalents & STI
110
97
89
Accounts Receivable, Net
11
12
14
Inventories
2
2
2
Total Current Liabilities
14
10
12
Payables & Accruals
8
6
8
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-239.98%
Free Cash Flow
- -
- -
15.49%
Net Income, GAAP
- -
- -
22.17%
Sales/Revenue/Turnover
- -
- -
85.94%
Total Cash Common Dividend
- -
- -
-1.35%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5
6
7
9
27
2025
10
12
13
15
51
2026
16
19
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.28
-0.33
-0.44
- -
-6.11
2025
-0.24
-0.26
-0.4
-0.32
-2.12
2026
-0.32
-0.39
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Michael Cordonnier
Full Time Employees
127
Sector
Healthcare
Industry
Medical - Devices
Address
1800 Aston Avenue Carlsbad CA United States of America 92008
IPO Date
Jul 23, 2025
Business
<x<x

Company News

  • Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform

  • Carlsmed, Inc. (CARL) Presents at Bank of America SMID Cap Virtual Conference Transcript

  • Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript

  • Carlsmed Q2 Earnings Call Highlights

  • Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates

  • Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

  • Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

  • Carlsmed, Inc. To Participate in Upcoming Investor Conferences

  • Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026

  • Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

  • Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

  • Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

  • Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

  • Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

  • Carlsmed® Reports First Quarter 2026 Financial Results

  • Carlsmed, Inc. To Participate in Upcoming Investor Conferences

  • Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf

  • Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

  • Comparing MiniMed Group (NASDAQ:MMED) and Carlsmed (NASDAQ:CARL)

  • Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference